Derma Cal Plus, herbal skin cream for children aged between 2 months to 5 years of age suffering from Eczema: A Double Blind Randomized Placebo Controlled Trial

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Dr Vivek Wayse
Scientific

19 Lakehall Gardens
Thornton Heath
Surrey
CR7 7EL
United Kingdom

Phone	+44 (0)20 8664 8720

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Not provided at time of registration
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Eczema
Intervention	Topical application of Derma Cal Plus cream or placebo. Follow-up each month by questionnaire.
Intervention type	Drug
Phase	Not Specified
Drug / device / biological / vaccine name(s)	Derma Cal Plus
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	31/12/2004

Participant type(s)	Patient
Age group	Child
Upper age limit	5 Years
Sex	Not Specified
Key inclusion criteria	1. Children less than 5 years of age 2. Children with mild or moderate atopic eczema within the past month 3. Children whose parent gives informed consent
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/01/2003
Date of final enrolment	31/12/2004

19 Lakehall Gardens

Surrey
CR7 7EL
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan